 IC due to atherosclerosis, we suggest against using warfarin for the sole
indication of reducing the risk of adverse cardiovascular events or vascular occlusions.
We suggest against using folic acid and vitamin B12 supplements as a treatment of IC.
In patients with IC who do not have congestive heart failure, we suggest a 3-month trial of
cilostazol (100 mg twice daily) to improve pain-free walking.
In patients with IC who cannot tolerate or